Novartis reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novartis using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-28 | $2.25 | $2.29 | -1.75 % |
| Q2 | 2025-07-17 | $2.47 | $2.38 | 3.78 % |
| Q1 | 2025-04-29 | $2.28 | $2.08 | 9.62 % |
| Q4 | 2025-01-31 | $1.98 | $1.79 | 10.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-28 | $13.91B | $13.87B | 0.30 % |
| Q2 | 2025-07-17 | $14.05B | $14.06B | -0.08 % |
| Q1 | 2025-04-29 | $13.23B | $12.99B | 1.87 % |
| Q4 | 2025-01-31 | $13.15B | $12.77B | 3.00 % |
Novartis (NVS) is scheduled to report earnings on February 4, 2026. The last reported earnings were for reported on October 28, 2025 for Q3.
The Actual EPS was $2.25, which missed the estimate of $2.29.
The Actual Revenue was $13.9B, which beat the estimate of $13.9B.
Browse earnings estimates, EPS, and revenue on all stocks.